Form D · Other Health Care
Lumere, Inc.
Chicago, IL · CIK 0001602203
Offering snapshot reported Feb 1, 2019 · SEC filing
- Reported sold
- $4.98M Offering amount: $4.98M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 4, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 1, 2019 | Initial | $4,978,136 | No comparison | 17 | SEC filing |
| Mar 14, 2014 | Initial | $1,275,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-331936
Source: Form D, filed Feb 1, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jesse Bland | Director |
| Michael Blaszyk | Director |
| John Burch | Director |
| John R. Burch, Jr. | Director |
| Will Danford | Executive |
| Hani Elias | Director, Executive |
| James Fitzgerald | Director |
| Eric Meizlish | Director, Executive |
| Bijan Salehizadeh | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
33 North Lasalle Street Suite 1500
Chicago, IL, 60602
Chicago, IL, 60602